HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

ALCHEMIST <span style="font-weight:normal"><i>(The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)</i></span>: Questions and Answers

treatment  trial  drug  screening  lung  tumor  genetic  childhood acute lymphoblastic leukemia  T-cell childhood acute lymphoblastic leukemia  Philadelphia chromosome-positive childhood acute lymphoblastic leukemia  gene  marker  mutation  ALK  EGFR  survival  ALCHEMIST 

ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol

Preview   0 Users liked this content.
NCI

Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version

childhood acute lymphoblastic leukemia  T-cell childhood acute lymphoblastic leukemia  Philadelphia chromosome-positive childhood acute lymphoblastic leukemia 

Childhood acute lymphoblastic leukemia (ALL) treatment is usually chemotherapy given in phases and determined by risk group. Radiation therapy, targeted therapy and stem cell transplant are sometimes used. Learn more about newly diagnosed and recurrent ALL in this expert reviewed summary.

Preview   0 Users liked this content.
NCI

Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version

childhood acute lymphoblastic leukemia  T-cell childhood acute lymphoblastic leukemia  Philadelphia chromosome-positive childhood acute lymphoblastic leukemia 

For acute lymphoblastic leukemia (ALL), the 5-year survival rate has improved significantly since 1975. Get information about risk factors, signs, diagnosis, molecular features, survival, risk-based treatment assignment, and induction and postinduction therapy for children and adolescents with newly diagnosed and recurrent ALL.

Preview   0 Users liked this content.
NCI

Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version

treatment  childhood  acute  leukemia  patient  version  lymphoblastic  childhood acute lymphoblastic leukemia  T-cell childhood acute lymphoblastic leukemia  Philadelphia chromosome-positive childhood acute lymphoblastic leukemia 

Childhood acute lymphoblastic leukemia (ALL) treatment is usually chemotherapy given in phases and determined by risk group. Radiation therapy, targeted therapy and stem cell transplant are sometimes used. Learn more about newly diagnosed and recurrent ALL in this expert reviewed summary.

Preview   0 Users liked this content.
NCI

Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version

health  treatment  childhood  acute  leukemia  version  professional  lymphoblastic  childhood acute lymphoblastic leukemia  T-cell childhood acute lymphoblastic leukemia  Philadelphia chromosome-positive childhood acute lymphoblastic leukemia 

For acute lymphoblastic leukemia (ALL), the 5-year survival rate has improved significantly since 1975. Get information about risk factors, signs, diagnosis, molecular features, survival, risk-based treatment assignment, and induction and postinduction therapy for children and adolescents with newly diagnosed and recurrent ALL.

Preview   0 Users liked this content.